Quintiles Wins Pfizer Development Operations Strategic Supplier Excellence Award
RESEARCH TRIANGLE PARK, NC-Quintiles Transnational Corp. today announced that its Data Management division has received the 2008 Pfizer Development Operations’ Strategic Supplier Excellence Award.
Pfizer presents the award to their Development Operations Functional Service Providers (FSPs) that demonstrate consistent and excellent performance in four areas: quality; service delivery and reliability; innovation and business processes; and customer service and responsiveness.
“Quintiles has consistently demonstrated superior performance and partnership by working to reduce timelines and streamline processes, adding high value to the Data Management business,” said Rob Goodwin, Vice President of Global Clinical Data Services, Pfizer.
Quintiles executives said the value of the partnership is enhanced by the strength of the Pfizer-Quintiles relationship.
“The Pfizer and Quintiles teams have worked closely together to lock databases ahead of schedule, increase productivity and achieve cost savings,” said Theo Erasmus, Vice President, Global Data Management, Quintiles Africa, who heads the FSP with Pfizer. “A major reason for our successful relationship is proactive communication. By maintaining an open dialogue, we’ve been able to increase quality, improve processes and encourage innovation.”
“We are honored and delighted to be selected for this award because it recognizes what can be achieved through open, honest collaboration and teamwork,” said Paula Brown Stafford, Executive Vice President, Integrated Clinical Services, Quintiles. “We look forward to building an even stronger relationship with our colleagues at Pfizer and building on our successes for 2009.”
Quintiles supports Pfizer data management primarily from locations in Bloemfontein, South Africa and Bangalore, India.
About Quintiles
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of 23,000 engaged professionals in more than 50 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
